Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2003
02/04/2003US6515108 Genetically engineered proteins for use in the treatment of cancer, cardiovascular, neurological and developmental disorders
02/04/2003US6515107 Human metabotropic glutamate receptor 7 subtypes
02/04/2003US6515105 Vascular Endothelial Growth Factor binding to extracellular domain of NP-1 (Neuropilin-1); bioactive complexes; mediate useful cell responses or antagonize undesired biological activities; angiogenesis; cell differentiation
02/04/2003US6515104 Therapeutic peptide-based constructs derived from domain II of bactericidal/permeability-increasing protein
02/04/2003US6515103 Polypeptides naturally occurring in venom of cone snails; include gamma-carboxyglutamic acid; use as anticonvulsant, neuroprotective, and pain management agents
02/04/2003US6515021 The compounds according to the invention have pronounced activity in the fields of cell differentiation and cell proliferation
02/04/2003US6514942 Nonapeptide induces Her-2 peptide reactive cytotoxic T-lymphocytes
02/04/2003US6514941 Solubilizing casein in an aqueous solvent and hydrolyzing the solubilized casein with an agent (e.g., a protease) that does not cleave the C6, C7 and C12 peptides, resulting hydrolysate is fractionated
02/04/2003US6514939 Mutants of atrial natriuretic factor that are protective for stroke
02/04/2003US6514938 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
02/04/2003US6514936 Antiviral methods using human rhinovirus receptor (ICAM-1)
02/04/2003US6514935 Methods of treating hypertension
02/04/2003US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases
02/04/2003US6514760 New MADS-box gene in a distinct phylogenetic group separate from those functioning in floral organs; genetic deletions; abscission; improved fruit harvesting
02/04/2003US6514757 Given sequence for Nodamura RNA1 genome segment; can be used as vector for abundant expression of genes in which RNA replicases and cis-elements amplify a transcript containing a heterologous gene by RNA replication
02/04/2003US6514754 Of herpesvirus of turkeys (HVT) inserted in a non-essential region of the vector; may be manipulated to provide vaccines
02/04/2003US6514753 Expression vectors for producing modified proteins
02/04/2003US6514752 Homologous recombination for universal donor cells and chimeric mammalian hosts
02/04/2003US6514747 Agouti polynucleotide compositions and methods of use
02/04/2003US6514745 Oncoprotein protein kinase
02/04/2003US6514738 Given amino acid sequence; microtubular depolymerization activity in presence of ATP; can be used in diagnosis and treatment of cancer, neurological and vesicular transport disorders.
02/04/2003US6514736 Oligonucleotide primers which also contain a non-complemetary sequence, labeled probes, and a thermostable DNA polymerase enzyme;
02/04/2003US6514735 Isolated protein of given amino acid sequence.
02/04/2003US6514731 Which incorporate major immunodominant epitopes; antigens provide sensitivity and specificity; Immunoassay
02/04/2003US6514730 Secretion of hirudin derivatives
02/04/2003US6514729 Recombinant interferon-beta muteins
02/04/2003US6514728 Process for preparation of cytokines using Sendai virus expression system
02/04/2003US6514727 Isolated nucleic acid molecule encoding a cyclic peptide having amino acids linked by peptide bonds and interchain crosslinks.
02/04/2003US6514725 STAT function-regulatory protein
02/04/2003US6514724 Isolated polynucleotide encoding a polypeptide which has high binding affinity.
02/04/2003US6514715 Genetic engineering; detecting binding
02/04/2003US6514712 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas
02/04/2003US6514701 Antimicrobial peptides and methods of use thereof
02/04/2003US6514697 Methods for detection of Crytosporidium species and isolates and for diagnosis of Cryptosporidium infections
02/04/2003US6514696 Detection thereof; Using polynucleotide that hybridizes to given nucleotide sequence; Cancer
02/04/2003US6514694 Detecting parasite oocysts in feces by contacting feces sample with a solid support capable of binding oocysts, dryin, washing, adding elution solution and eluting DNA from sample by heating, PCR amplification with primers
02/04/2003US6514692 Method for treatment of immunodeficiency virus infection
02/04/2003US6514691 An antigenic envelope polypeptide of given amino acid sequence was identified
02/04/2003US6514690 Immunoreactive antigens of Hepatitis E Virus
02/04/2003US6514533 Device for the sustained release of aggregation-stabilized, biologically active agent
02/04/2003US6514501 Recombinant vaccine against dengue virus
02/04/2003US6514500 Long lasting synthetic glucagon like peptide {GLP-!}
02/04/2003US6514498 Modified/chimeric superantigens and their use
02/04/2003US6514497 Inhibition of LERK-2-mediated cell adhesion
02/04/2003US6514493 Amino acid sequence encoding an amino-terminal protein fragment of murine glycoprotein 110
02/04/2003CA2274870C Control of microsporogenesis by externally inducible promoter sequences
02/04/2003CA2271478C Tissue specific expression of retinoblastoma protein
02/04/2003CA2205405C Method for treating secondary immunodeficiency
02/04/2003CA2171953C Modified truncated complement system regulators
02/04/2003CA2164692C Recombinant spider silk analogs
02/04/2003CA2116126C Process for controlling lepidopteran pests
02/04/2003CA2095633C Enrichment method for variant proteins with altered binding properties
02/04/2003CA2063810C Production of vascular endothelial cell growth factor
02/04/2003CA2060325C Polypeptides with a dopaminergic receptor activity; nucleic acids coding for these polypeptides and use of the latter for screening active substances on said polypeptides
02/04/2003CA2057313C Method of producing pathogen-resistant plants
02/03/2003WO2002016548A2 Novel g protein-coupled receptor
02/03/2003WO2002012553A2 Method for detecting mutations in nucleotide sequences
02/03/2003CA2418130A1 Novel g protein-coupled receptor
02/03/2003CA2417861A1 Method for detecting mutations in nucleotide sequences
02/03/2003CA2391627A1 Ribosome structure and protein synthesis inhibitors
02/02/2003CA2353777A1 Mitochondrial protein
01/2003
01/31/2003WO2002012338A2 Screening method
01/31/2003CA2417972A1 Screening method
01/31/2003CA2391621A1 Novel variants of the human cyp2d6 gene
01/30/2003WO2003008932A2 Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy akylene glycols
01/30/2003WO2003008649A1 Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin
01/30/2003WO2003008640A2 Asthma-associated gene
01/30/2003WO2003008627A2 Phenylthiocarbamide (ptc) taste receptor
01/30/2003WO2003008625A2 Structural and cytoskeleton-associated proteins
01/30/2003WO2003008621A2 87144, human amino acid transporter family member and uses therefor
01/30/2003WO2003008598A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
01/30/2003WO2003008597A2 Regulation of peroxisomal fatty acid transport in plants
01/30/2003WO2003008594A1 Construction of the plasmid for expressing the thrombus-targeting thrombolytic fusion protein
01/30/2003WO2003008589A1 Elk1 PHOSPHORYLATION-ASSOCIATED GENE
01/30/2003WO2003008586A2 Engineering oncolytic viruses
01/30/2003WO2003008585A2 Nucleic acids coding for a isum2a polypeptide and use of said nucleic acids to obtain transformed plants producing seeds altered in germ development
01/30/2003WO2003008583A2 Novel compositions and methods for cancer
01/30/2003WO2003008582A1 Novel human-origin protein binding to sphingosine kinase 1 and polynucleotide encoding the protein
01/30/2003WO2003008581A1 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING APOPTOSIS REGULATOR
01/30/2003WO2003008580A1 Galectin-14 therapeutic molecule and uses thereof
01/30/2003WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
01/30/2003WO2003008578A2 Reagents and methods for identifying gene targets for treating cancer
01/30/2003WO2003008574A1 Mutations in ion channels
01/30/2003WO2003008571A2 Chimeric chains that code for proteins that induce effects directed against viruses
01/30/2003WO2003008567A1 The tumor angiogenesis inhibitory factor-expressed efficiently virus specifically proliferating in tumor cell and uses thereof
01/30/2003WO2003008560A2 A novel g protein-coupled receptor, gave8
01/30/2003WO2003008557A2 Activators of cyclin-dependent kinases
01/30/2003WO2003008548A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology
01/30/2003WO2003008541A2 Extracellular junctional adhesion molecules
01/30/2003WO2003008540A2 Abiotic stress responsive polynucleotides and polypeptides
01/30/2003WO2003008537A2 Epitope sequences
01/30/2003WO2003008455A1 Activity monitor molecules for g-protein trimer
01/30/2003WO2003008454A2 Glycoprotein vi fusion proteins
01/30/2003WO2003008453A1 Method for immobilization of polypeptides
01/30/2003WO2003008450A1 Tumor antigen
01/30/2003WO2003008449A1 Ntb-a, a surface molecule involved in natural killer cells activity
01/30/2003WO2003008448A2 Novel human proton-gated channels
01/30/2003WO2003008447A1 Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination
01/30/2003WO2003008446A1 Polypeptides relating to signal transfer of advanced glycation end product receptor
01/30/2003WO2003008445A1 Novel g protein-coupled receptor protein and dna thereof